Key result
Skeletal muscle knockout of Nox4 provided full protection against loss of diaphragm maximal force in HFrEF mice, while Nox2 knockout provided partial protection.
Why the study?
Diaphragm weakness in HFrEF is linked to excessive reactive oxygen species, but the exact source of ROS and the role of skeletal muscle Nox2 and Nox4 remain unknown.
Does skeletal muscle specific knockout of Nox2 or Nox4 prevent loss of maximal diaphragm force in a mouse model of HFrEF?
Does skeletal muscle specific knockout of Nox2 or Nox4 prevent loss of maximal diaphragm force in a mouse model of HFrEF?
Skeletal muscle Nox4 and Nox2 contribute to diaphragm weakness in HFrEF, and their targeted knockout preserves diaphragm force and improves survival in a mouse model.
Answers are grounded in this paper and cite their sources.
Nox4 may mediate diaphragm weakness in experimental HFrEF; leaves open translation to human therapies.
Patients with heart failure with reduced ejection fraction (HFrEF) experience diaphragm weakness that contributes to the primary disease symptoms of fatigue, dyspnea, and exercise intolerance. Weakness in the diaphragm is related to excessive production of reactive oxygen species (ROS), but the exact source of ROS remains unknown. NAD(P)H Oxidases (Nox), particularly the Nox2 and 4 isoforms, are important sources of ROS within skeletal muscle that contribute to optimal cell function. There are reports of increased Nox activity in the diaphragm of patients and animal models of HFrEF, implicating these complexes as possible sources of diaphragm dysfunction in HFrEF. To investigate the role of these proteins on diaphragm weakness in HFrEF, we generated inducible skeletal muscle specific knockouts of Nox2 or Nox4 using the Cre-Lox system and assessed diaphragm function in a mouse model of HFrEF induced by myocardial infarction. Diaphragm maximal specific force measured in vitro was depressed by ∼20% with HFrEF. Skeletal muscle knockout of Nox4 provided full protection against the loss of maximal force (p < 0.01), while the knockout of Nox2 provided partial protection (7% depression, p < 0.01). Knockout of Nox2 from skeletal myofibers improved survival from 50 to 80% following myocardial infarction (p = 0.026). Our findings show an important role for skeletal muscle NAD(P)H Oxidases contributing to loss of diaphragm maximal force in HFrEF, along with systemic pathophysiological responses following myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2022) studied Heart failure with reduced ejection fraction (HFrEF). Skeletal muscle specific knockouts of Nox2 or Nox4 vs. Control mice with HFrEF was evaluated on Diaphragm maximal specific force (p=<0.01). Skeletal muscle knockout of Nox4 provided full protection against loss of diaphragm maximal force in HFrEF mice, while Nox2 knockout provided partial protection.
Synapse has enriched 10 related papers. Consider them for comparative context: